US Drug Recall Register

Is Chloride recalled?

Yes — there is an active recall. 326 ongoing FDA recalls mention Chloride (1,994 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Chloride. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.

Class II · Moderate risk Terminated

Phenylephrine HCL PF INJ in 0.9% Sodium Chloride

Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.

Premier Pharmacy Labs Inc D-1424-2019
Class I · High risk Terminated

Hydromorphone HCl in 0.9% sodium chloride

Reason Incorrect Product Formulation; Firm's customer resource center (CRC) statement indicates that the product is sulfite free, however the product is produced with a raw material that contains sulfite

PharMEDium Services, LLC NDC 61553-352-78 D-1488-2019
Class II · Moderate risk Terminated

Lipo MIC-12

Reason Lack of Sterility Assurance.

Pharm D Solutions, LLC D-1328-2019
Class II · Moderate risk Terminated

Cetirizine Hydrochloride Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc NDC 13668-029-07 D-1381-2019
Class II · Moderate risk Terminated

Cetirizine Hydrochloride Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc NDC 23155-292-51 D-1380-2019
Class II · Moderate risk Terminated

Memantine Hydrochloride Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1375-2019
Class II · Moderate risk Terminated

Memantine Hydrochloride Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1374-2019
Class II · Moderate risk Terminated

Cyproheptadine Hydrochloride Syrup Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1358-2019
Class II · Moderate risk Terminated

Banophen Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1352-2019
Class II · Moderate risk Terminated

Pramipexole Dihydrochloride Tablets

Reason GMP Deviations; possible cross contamination of product due to cleaning procedure failure.

American Health Packaging D-1434-2019
Class II · Moderate risk Terminated

Pramipexole Dihydrochloride Tablets

Reason GMP Deviations; possible cross contamination of product due to cleaning procedure failure.

American Health Packaging D-1433-2019
Class II · Moderate risk Terminated

Pramipexole Dihydrochloride Tablets

Reason GMP Deviations; possible cross contamination of product due to cleaning procedure failure.

American Health Packaging D-1432-2019
Class II · Moderate risk Terminated

Pramipexole Dihydrochloride Tablets

Reason GMP Deviations; possible cross contamination of product due to cleaning procedure failure.

American Health Packaging D-1431-2019
Class II · Moderate risk Terminated

Pramipexole Dihydrochloride Tablets 1 mg

Reason CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Zydus Pharmaceuticals USA Inc NDC 68382-199-16 D-1447-2019
Class II · Moderate risk Terminated

Pramipexole Dihydrochloride Tablets 0.5 mg

Reason CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Zydus Pharmaceuticals USA Inc NDC 68382-198-16 D-1446-2019
Class II · Moderate risk Terminated

Pramipexole Dihydrochloride Tablets 0.25 mg

Reason CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Zydus Pharmaceuticals USA Inc NDC 68382-197-10 D-1445-2019
Class II · Moderate risk Terminated

Pramipexole DihydrochlorideTablets 0.125 mg

Reason CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Zydus Pharmaceuticals USA Inc NDC 68382-196-16 D-1443-2019
Class II · Moderate risk Terminated

Pramipexole Dihydrochloride Tablets 0.125 mg

Reason CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Zydus Pharmaceuticals USA Inc NDC 68382-196-10 D-1442-2019
Class II · Moderate risk Terminated

Articaine DENTAL

Reason Labeling: Not Elsewhere Classified. This recall has been initiated due to mislabeling. The printed carton used in manufacturing both batches contained text for both 2% Xylocaine DENTAL and Articadent DENTAL. Xylocaine DENTAL is a trade name for Lidocaine HCL 2% and Epinephrine 1: 100,000 formulation, while Articadent DENTAL is a trade name for Articaine HCI 4% and Epinephrine 1 :100,000. The cartridges contained within the printed carton are labeled appropriately as Articadent DENTAL.

Septodont Inc. NDC 66312-601-16 D-1307-2019
Class II · Moderate risk Terminated

AQUACIL instant foaming hand sanitizer

Reason CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.

Inopak Ltd D-1311-2019
Class II · Moderate risk Terminated

DelNido Cardioplegia

Reason Lack of sterility assurance.

CMC Enterprise Pharmacy D-1240-2019